Srutinizer Report for the 33rd AGM held on 29th September 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Limited held its 33rd Annual General Meeting on 29th September 2025 via video conferencing, where all 18 resolutions were passed with the required majority. On a total share base of 4,55,36,256 shares, about 1,44,50,678 votes (31.73%) were polled, of which over 99.6% voted in favour of most resolutions. Key items included adoption of FY25 audited financial statements, re-appointment of three directors, increase in authorised share capital, appointment of Whole-time Directors and an Independent Director, and approval of material related party transactions with six subsidiaries. A special resolution was also passed to approve disinvestment from Dindigul Farm Product Limited. M/s. KRA & Associates acted as the scrutinizer for the remote e-voting and e-voting at the AGM process.
Shareholders have approved a higher authorised share capital and several related-party transactions with subsidiaries, which could lead to future fund-raising or restructuring. The overwhelming approval (over 99% in favour) on all resolutions signals strong promoter and shareholder support, with minimal dissent on governance matters.